IP Library Granted Patent US 6,918,991
Granted Patent B2
US 6,918,991 · App. 10/752,910 · Granted Jul 19, 2005

Methods and apparatus for making particles using spray dryer and in-line jet mill

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,918,991
App. No.
10/752,910
Granted
Jul 19, 2005
Kind
B2
Abstract

Methods and apparatus are provided for making particles comprising: (a) spraying an emulsion, solution, or suspension, which comprises a solvent and a bulk material (e.g., a pharmaceutical agent), through an atomizer and into a primary drying chamber, having a drying gas flowing therethrough, to form droplets comprising the solvent and bulk material dispersed in the drying gas; (b) evaporating, in the primary drying chamber, at least a portion of the solvent into the drying gas to solidify the droplets and form particles dispersed in drying gas; and (c) flowing the particles and at least a portion of the drying gas through a jet mill to deagglomerate or grind the particles. By coupling spray drying with “in-line” jet milling, a single step process is created from two separate unit operations, and an additional collection step is advantageously eliminated. The one-step, in-line process has further advantages in time and cost of processing.

Claims (37)

1. A method for making a dry powder blend comprising:

(a) spraying an emulsion, solution, or suspension, which comprises a solvent and a bulk material, through an atomizer and into a primary drying chamber having a drying gas inlet, a discharge outlet, and a drying gas flowing therethrough, to form droplets comprising the solvent and the bulk material, wherein the droplets are dispersed in the drying gas;

(b) evaporating, in the primary drying chamber, at least a portion of the solvent into the drying gas to solidify the droplets and form particles dispersed in the drying gas, the particles dispersed in the drying gas being a feedstream;

(c) adding a dry powder material to the feedstream to form a combined feedstream; and

(d) flowing the combined feedstream through an inline jet mill to deagglomerate or grind the particles and dry powder material of the combined feedstream, wherein the jet mill comprises a spiral jet mill or other fluid energy impact mill.

2. The method of claim 1 , wherein after step (b) and before step (c) the feedstream is directed through a particle concentration means to separate and remove at least a portion of the drying gas from the feedstream.

3. The method of claim 2 , wherein the particle concentration means comprises at least one cyclone separator.

4. The method of claim 3 , wherein the at least one cyclone separator separates between about 50 and 100 vol. % of the drying gas from the particles.

5. The method of claim 1 , wherein the combined feedstream after step (c) and before step (d) is directed through a particle concentration means to separate and remove at least a portion of the drying gas from the combined feedstream.

6. The method of claim 5 , wherein the particle concentration means comprises at least one cyclone separator.

7. The method of claim 1 , wherein step (d) deagglomerates at least a portion of agglomerated particles, if any, while substantially maintaining the size and morphology of the individual particles.

8. The method of claim 1 , wherein the particles comprise a pharmaceutical agent and the dry powder material is selected from the group consisting of an excipient material, a second pharmaceutical agent, and combinations thereof.

9. The method of claim 1 , wherein the particles are microparticles comprising a pharmaceutical agent and the dry powder material is in the form of microparticles having a size that is larger than the size of the microparticles which comprise the pharmaceutical agent.

10. The method of claim 1 , further comprising after step (b) and before step (c) flowing the feedstream through a jet mill to deagglomerate or grind the particles.

11. A method for making a dry powder pharmaceutical blend comprising:

(a) spraying an emulsion, solution, or suspension, which comprises a solvent and a bulk material which comprises a pharmaceutical agent, through an atomizer and into a primary drying chamber having a drying gas inlet, a discharge outlet, and a drying gas flowing therethrough, to form droplets comprising the solvent and the bulk material, wherein the droplets are dispersed in the drying gas;

(b) evaporating, in the primary drying chamber, at least a portion of the solvent into the drying gas to solidify the droplets and form microparticles dispersed in the drying gas, the microparticles dispersed in the drying gas together forming a feedstream;

(c) adding a dry powder material to the feedstream to form a combined feedstream, the dry powder material being selected from the group consisting of an excipient material, a second pharmaceutical agent, and combinations thereof; and

(d) flowing the combined feedstream through an inline jet mill to deagglomerate or grind the microparticles and dry powder material of the combined feedstream, wherein the jet mill comprises a spiral jet mill or other fluid energy impact mill.

12. The method of claim 11 , wherein step (d) deagglomerates at least a portion of agglomerated microparticles, if any, while substantially maintaining the size and morphology of the individual particles.

13. The method of claim 11 , wherein the dry powder material is in the form of microparticles having a size that is larger than the size of the microparticles which comprise the pharmaceutical agent.

14. An in-line process for making a dry powder blend comprising:

(a) spraying an emulsion, solution, or suspension, which comprises a solvent and a bulk material, through an atomizer and into a primary drying chamber having a drying gas inlet, a discharge outlet, and a drying gas flowing therethrough, to form droplets comprising the solvent and the bulk material, wherein the droplets are dispersed in the drying gas;

(b) evaporating, in the primary drying chamber, at least a portion of the solvent into the drying gas to solidify the droplets and form particles dispersed in the drying gas, the particles dispersed in the drying gas being a feedstream;

(c) flowing the feedstream through a first inline jet mill to deagglomerate or grind the particles, wherein the first jet mill comprises a spiral jet mill or other fluid energy impact mill;

(d) adding a dry powder material to the feedstream to form a combined feedstream; and

(e) optionally flowing the combined feedstream through a second inline jet mill to deagglomerate or grind the particles and dry powder material of the combined feedstream.

15. The process of claim 14 , wherein the feedstream after step (b) and before step (c) is directed through a particle concentration means to separate and remove at least a portion of the drying gas from the feedstream.

16. The process of claim 15 , wherein the particle concentration means comprises at least one cyclone separator.

17. The process of claim 14 , wherein the combined feedstream after step (d) and before step (e) is directed through a particle concentration means to separate and remove at least a portion of the drying gas from the combined feedstream.

18. The process of claim 17 , wherein the particle concentration means comprises at least one cyclone separator.

19. The process of claim 14 , wherein step (c) or step (e) deagglomerate at least a portion of agglomerated particles, if any, while substantially maintaining the size and morphology of the individual particles.

20. The process of claim 14 , wherein the particles comprise a pharmaceutical agent and the dry powder material is selected from the group consisting of an excipient material, a second pharmaceutical agent, and combinations thereof.

21. The process of claim 14 , wherein the particles are microparticles comprising a pharmaceutical agent and the dry powder material is in the form of microparticles having a size that is larger than the size of the microparticles which comprise the pharmaceutical agent.

22. A pharmaceutical composition comprising a dry powder blend made the method of claim 1 .

23. A pharmaceutical blend made by claim 11 .

24. A pharmaceutical composition comprising a dry powder blend made the process of claim 14 .

Assignments (1)
SECURITY AGREEMENT Recorded Nov 3, 2008
From: ACUSPHERE, INC.
To: CEPHALON, INC.
Reel/Frame 021773/0477 →